Xellia
Xellia ApS is a Danish multinational pharmaceutical and life sciences company headquartered in Copenhagen specialized in the production of anti-biotics, including Vancomycin and Bacitracin.
The company's US base of operations is in Buffalo Grove, Illinois, with additional facilities in Ohio, and North Carolina. In 2018, Xellia's sales in the United States accounted for 60% of its total revenue.
Products
The company's main output is bulk drug chemicals which are wholesaled to other companies for packaging and distribution. Recently some prepackaged goods have been produced.Active drug substances manufactured are:
| ATC | Substance | Structural formula | Formulation for sale | Production started |
| D06AX05 J01XX10 R02AB04 QA07AA93 | Bacitracin | Bacitracin | 1952 | |
| D06AX05 J01XX10 R02AB04 QA07AA93 | Bacitracin | Bacitracin zinc | 1958 | |
| Colistimethate natrium | ||||
| A07AA10 J01XB01 QJ51XB01 | Colistin | Colistin sulfate | 1969 | |
| J01X X09 | Daptomycin | Daptomycin | ||
| R02AB30 | Gramicidin | |||
| A07AA05 J01XB02 S01AA18 S02AA11 S03AA03 QJ51XB02 | Polymyxin B | Polymyxin B-sulfate | 1968 | |
| J01GB01 S01AA12 | Tobramycin | Tobramycin sulfate | 2005 | |
| D06AX08 R02AB02 S01AA05 | Tyrothricin | Tyrothricin | ||
| A07AA09 J01XA01 | Vancomycin | Vancomycin hydrochloride | 2003 | |
| A01AB04 A07AA07 G01AA03 J02AA01 | Amfotericin B | Amfotericin B | 1985 | |
| J02AX04 | Caspofungin | Caspofungin acetate | ||
| D07AC17 R01AD08 R01AD58 R03BA05 | Fluticasone | Fluticasone propionate | ||
| D07AC13 R01AD09 R03BA07 | Mometasone | Mometasone furoate |
Discontinued products
Previously the company also produced:| Ingredient | Produced |
| Neomycin | 1952-? |
| Tetracycline | 1961-? |